Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)
Brazil · Delayed Price · Currency is BRL 66.00
-1.28 (-1.90%)
At close: Dec 2, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 393.75 billion as of December 4, 2025. Its market cap has decreased by -16.47% in one year.
Market Cap
393.75B
Enterprise Value
308.78B
Revenue
75.93B
Ranking
n/a
PE Ratio
16.14
Stock Price
66.00
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 177.17M to 393.75B, an increase of 222,150.63%. That is a compound annual growth rate of 25.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 392.95B | -17.10% |
| Dec 31, 2024 | 474.01B | 4.59% |
| Dec 29, 2023 | 453.22B | 11.26% |
| Dec 30, 2022 | 407.37B | 10.73% |
| Dec 31, 2021 | 367.89B | 38.93% |
| Dec 31, 2020 | 264.80B | 60.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.37B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |